PNC Financial Services Group
CLRB icon

PNC Financial Services Group’s Cellectar Biosciences CLRB Stock Holding History

PNC Financial Services Group’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$1.19K – 4778
2024
Q1 		$1.19K Buy
+10
New +$1.08K ﹤0.01% 4328
2021
Q4 		– Sell
-33
Closed -$9K – 4459
2021
Q3 		$9K Hold
33
– – ﹤0.01% 3777
2021
Q2 		$12K Hold
33
– – ﹤0.01% 3642
2021
Q1 		$16K Hold
33
– – ﹤0.01% 3487
2020
Q4 		$21K Hold
33
– – ﹤0.01% 3315
2020
Q3 		$12K Hold
33
– – ﹤0.01% 3432
2020
Q2 		$13K Hold
33
– – ﹤0.01% 3376
2020
Q1 		$13K Hold
33
– – ﹤0.01% 3301
2019
Q4 		$23K Buy
+33
New +$17.2K ﹤0.01% 3265

Other funds holding CLRB

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PNC Financial Services Group's CLRB Position: Q2 2024 in Review

PNC Financial Services Group sold out of Cellectar Biosciences (CLRB) in Q2 2024, closing a stake of 10 shares — an estimated $1.19K sold.

PNC Financial Services Group first reported a position in CLRB in Q4 2019 and held it in 9 quarters. The position peaked at $23K in Q4 2019. 37 funds tracked by Wall St. Rank hold CLRB as of Q2 2024.

  • PNC Financial Services Group reported no remaining Cellectar Biosciences position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 10 Cellectar Biosciences shares in Q2 2024, an estimated $1.19K.
  • PNC Financial Services Group first reported a position in Cellectar Biosciences in Q4 2019 and held it in 9 quarters.
  • PNC Financial Services Group's Cellectar Biosciences position peaked at $23K in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.